v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
General and administrative costs [1] $ 1,276,888 $ 185,052 $ 1,600,933 $ 235,194
Loss from operations (1,276,888) (185,052) (1,600,933) (235,194)
Other income:        
Gain on expiration of Over-Allotment Option liability   159,084   159,084
Interest earned on marketable securities held in Trust Account 1,364,288 834,274 2,713,663 834,274
Other income 1,364,288 993,358 2,713,663 993,358
Net income 87,400 808,306 1,112,730 758,164
Class A Ordinary Shares        
Other income:        
Net income $ 66,083 $ 479,710 $ 841,332 $ 321,421
Weighted average shares outstanding, basic (in shares) 15,500,000 8,346,154 15,500,000 4,219,444
Weighted average shares outstanding, diluted (in shares) 15,500,000 8,346,154 15,500,000 4,219,444
Basic net income per Ordinary Share (in dollars per share) $ 0 $ 0.06 $ 0.05 $ 0.08
Diluted net income per Ordinary Share (in dollars per share) $ 0 $ 0.06 $ 0.05 $ 0.08
Class B Ordinary Shares        
Other income:        
Net income $ 21,317 $ 328,596 $ 271,398 $ 436,743
Weighted average shares outstanding, basic (in shares) [2] 5,000,000 5,717,033 5,000,000 5,733,333
Weighted average shares outstanding, diluted (in shares) [2] 5,000,000 5,717,033 5,000,000 5,733,333
Basic net income per Ordinary Share (in dollars per share) $ 0 $ 0.06 $ 0.05 $ 0.08
Diluted net income per Ordinary Share (in dollars per share) $ 0 $ 0.06 $ 0.05 $ 0.08
[1] The change in general and administrative expenses during the three-month period ended June 30, 2026 was primarily attributable to the recognition of accrued legal expenses of $1,107,266.
[2] Included up to 750,000 Class B Ordinary Shares subject to forfeiture if the Over-Allotment Option was not exercised in full or in part by the Underwriters. On June 26, 2025, upon the expiration of the 45-day period without the Underwriters exercising the Over-Allotment Option, 750,000 Class B Ordinary Shares were forfeited by the Sponsor.